Molecular analyses of 15,542 patients with suspected BCR-ABL1-negative myeloproliferative disorders allow to develop a stepwise diagnostic workflow

scientific article

Molecular analyses of 15,542 patients with suspected BCR-ABL1-negative myeloproliferative disorders allow to develop a stepwise diagnostic workflow is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3324/HAEMATOL.2012.064683
P932PMC publication ID3487560
P698PubMed publication ID22511494
P5875ResearchGate publication ID224284805

P50authorTorsten HaferlachQ66370751
Tamara AlpermannQ66370761
Ulrike BacherQ66370775
Claudia HaferlachQ66370782
Susanne SchnittgerQ66370791
Frank DickerQ114293331
Vera GrossmannQ114293334
Alexander KohlmannQ114293337
Christiane EderQ114293338
P2093author name stringWolfgang Kern
P2860cites workJAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosisQ24609999
Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disordersQ29614510
Frequent pathway mutations of splicing machinery in myelodysplasiaQ29616088
SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)Q30420638
MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasiaQ34770384
Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A.Q35346433
Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasmsQ36270713
TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosisQ36303447
Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia veraQ37112871
Genetic and epigenetic complexity in myeloproliferative neoplasmsQ37967274
Uses and abuses of JAK2 and MPL mutation tests in myeloproliferative neoplasms a paper from the 2010 William Beaumont hospital symposium on molecular pathologyQ42870230
LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutationsQ42931701
Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasmsQ47960630
LNK mutations in JAK2 mutation-negative erythrocytosis.Q54649906
Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 72.8% of Chronic Myelomonocytic Leukemia by Detecting Frequent Alterations in TET2, CBL, RAS, and RUNX1Q57740696
Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevanceQ58455666
An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRNAs in haematological disordersQ72726990
Report on two novel nucleotide exchanges in the JAK2 pseudokinase domain: D620E and E627EQ80000872
Detection of an MPLW515 mutation in a case with features of both essential thrombocythemia and refractory anemia with ringed sideroblasts and thrombocytosisQ80829715
P433issue10
P921main subjectworkflowQ627335
myeloproliferative disordersQ1898104
P304page(s)1582-1585
P577publication date2012-04-17
P1433published inHaematologicaQ5638209
P1476titleMolecular analyses of 15,542 patients with suspected BCR-ABL1-negative myeloproliferative disorders allow to develop a stepwise diagnostic workflow
P478volume97